Key statistics
On Monday, Waldencast PLC (WALD:NAQ) closed at 1.63, 12.41% above the 52 week low of 1.45 set on Jan 08, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.68 |
|---|---|
| High | 1.72 |
| Low | 1.62 |
| Bid | 0.656 |
| Offer | 1.87 |
| Previous close | 1.69 |
| Average volume | 57.06k |
|---|---|
| Shares outstanding | 128.04m |
| Free float | 53.80m |
| P/E (TTM) | -- |
| Market cap | 216.39m USD |
| EPS (TTM) | -1.80 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
- Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
- UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
- CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
More ▼
